An announcement from Nano-X Imaging ( (NNOX) ) is now available.
Nano-X Imaging Ltd announced its financial results for the fourth quarter of 2024, revealing a revenue increase to $3.0 million from $2.4 million in the same period of 2023. The company achieved regulatory successes with FDA clearance for the Nanox.ARC and a CE mark in the EU, advancing its global commercialization efforts. Despite a net loss of $14.1 million, the company is optimistic about its future, citing operational progress and new partnerships in the US and EU markets. These developments position Nano-X to drive its innovative technologies into a market eager for improved medical imaging solutions.
More about Nano-X Imaging
Nano-X Imaging Ltd is an innovative medical imaging technology company based in Petach Tikva, Israel. The company focuses on developing advanced imaging systems and AI solutions to enhance accessibility and reduce costs in the medical imaging industry. Their primary products include the Nanox.ARC and Nanox AI, which have recently achieved significant regulatory milestones.
YTD Price Performance: -41.04%
Average Trading Volume: 2,814,787
Technical Sentiment Signal: Buy
Current Market Cap: $306M
For detailed information about NNOX stock, go to TipRanks’ Stock Analysis page.